Audentes Therapeutics, Inc. – Underwriting Agreements – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Underwriting Agreements Filter

from 8-K 39 pages Audentes Therapeutics, Inc. (A Delaware Corporation) 5,200,000 Shares of Common Stock Underwriting Agreement

from S-3ASR 36 pages Audentes Therapeutics, Inc. $150,000,000 Common Stock Sales Agreement

from 8-K 36 pages Audentes Therapeutics, Inc. (A Delaware Corporation) 5,750,000 Shares of Common Stock Underwriting Agreement Dated: January 24, 2018 Audentes Therapeutics, Inc. (A Delaware Corporation) 5,750,000 Shares of Common Stock Underwriting Agreement

from S-3 36 pages Audentes Therapeutics, Inc. $75,000,000 Common Stock Sales Agreement

from S-1/A 38 pages Audentes Therapeutics, Inc. (A Delaware Corporation) [•] Shares of Common Stock Underwriting Agreement

from S-1/A 38 pages Audentes Therapeutics, Inc. (A Delaware Corporation) [●] Shares of Common Stock Underwriting Agreement